Last reviewed · How we verify
Renormax (SPIRAPRIL HYDROCHLORIDE)
Renormax (generic name: SPIRAPRIL HYDROCHLORIDE) is a spirapril drug. It is currently FDA-approved (first approved 1994) for Hypertensive disorder.
Renormax is a small molecule inhibitor of the angiotensin-converting enzyme, a type of enzyme involved in regulating blood pressure. It has been studied in clinical trials for various conditions, including post-stroke pneumonia, heart diseases, diabetes, and hypertension, often in combination with other treatments such as angiotensin converting enzyme inhibitors, Calcium Channel Blockers, and Angiotensin Receptor Blockers.
At a glance
| Generic name | SPIRAPRIL HYDROCHLORIDE |
|---|---|
| Drug class | spirapril |
| Target | Angiotensin-converting enzyme |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1994 |
Approved indications
- Hypertensive disorder
Common side effects
Key clinical trials
- Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
- NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients (PHASE4)
- Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Renormax CI brief — competitive landscape report
- Renormax updates RSS · CI watch RSS
Frequently asked questions about Renormax
What is Renormax?
What is Renormax used for?
What is the generic name of Renormax?
What drug class is Renormax in?
When was Renormax approved?
What development phase is Renormax in?
What does Renormax target?
Related
- Drug class: All spirapril drugs
- Target: All drugs targeting Angiotensin-converting enzyme
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertensive disorder
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing